IBDEI0WH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16039,1,4,0)
 ;;=4^249.00
 ;;^UTILITY(U,$J,358.3,16039,1,5,0)
 ;;=5^Secondary DM w/o Complication
 ;;^UTILITY(U,$J,358.3,16039,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,16040,0)
 ;;=249.40^^92^931^48
 ;;^UTILITY(U,$J,358.3,16040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16040,1,4,0)
 ;;=4^249.40
 ;;^UTILITY(U,$J,358.3,16040,1,5,0)
 ;;=5^Secondary DM w/ Renal Complications
 ;;^UTILITY(U,$J,358.3,16040,2)
 ;;=^336732
 ;;^UTILITY(U,$J,358.3,16041,0)
 ;;=249.60^^92^931^47
 ;;^UTILITY(U,$J,358.3,16041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16041,1,4,0)
 ;;=4^249.60
 ;;^UTILITY(U,$J,358.3,16041,1,5,0)
 ;;=5^Secondary DM w/ Neuro Complications
 ;;^UTILITY(U,$J,358.3,16041,2)
 ;;=^336734
 ;;^UTILITY(U,$J,358.3,16042,0)
 ;;=257.2^^92^931^31
 ;;^UTILITY(U,$J,358.3,16042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16042,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,16042,1,5,0)
 ;;=5^Hypogonadism
 ;;^UTILITY(U,$J,358.3,16042,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,16043,0)
 ;;=255.42^^92^931^38
 ;;^UTILITY(U,$J,358.3,16043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16043,1,4,0)
 ;;=4^255.42
 ;;^UTILITY(U,$J,358.3,16043,1,5,0)
 ;;=5^Mineralcorticoid Deficient
 ;;^UTILITY(U,$J,358.3,16043,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,16044,0)
 ;;=259.50^^92^931^2
 ;;^UTILITY(U,$J,358.3,16044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16044,1,4,0)
 ;;=4^259.50
 ;;^UTILITY(U,$J,358.3,16044,1,5,0)
 ;;=5^Androgen Insensitivity,Unspec
 ;;^UTILITY(U,$J,358.3,16044,2)
 ;;=^336738
 ;;^UTILITY(U,$J,358.3,16045,0)
 ;;=275.5^^92^931^18
 ;;^UTILITY(U,$J,358.3,16045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16045,1,4,0)
 ;;=4^275.5
 ;;^UTILITY(U,$J,358.3,16045,1,5,0)
 ;;=5^Hungry Bone Syndrome
 ;;^UTILITY(U,$J,358.3,16045,2)
 ;;=^336538
 ;;^UTILITY(U,$J,358.3,16046,0)
 ;;=793.2^^92^932^3
 ;;^UTILITY(U,$J,358.3,16046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16046,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,16046,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,16046,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,16047,0)
 ;;=277.6^^92^932^5
 ;;^UTILITY(U,$J,358.3,16047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16047,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,16047,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,16047,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,16048,0)
 ;;=493.92^^92^932^6
 ;;^UTILITY(U,$J,358.3,16048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16048,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,16048,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,16048,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,16049,0)
 ;;=493.20^^92^932^11
 ;;^UTILITY(U,$J,358.3,16049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16049,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,16049,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,16049,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,16050,0)
 ;;=493.91^^92^932^7
 ;;^UTILITY(U,$J,358.3,16050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16050,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,16050,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;^UTILITY(U,$J,358.3,16050,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,16051,0)
 ;;=491.21^^92^932^10
 ;;^UTILITY(U,$J,358.3,16051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16051,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,16051,1,5,0)
 ;;=5^COPD Exacerbation
 ;;^UTILITY(U,$J,358.3,16051,2)
 ;;=COPD Exacerbation^269954
 ;;^UTILITY(U,$J,358.3,16052,0)
 ;;=494.0^^92^932^9
 ;;^UTILITY(U,$J,358.3,16052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16052,1,4,0)
 ;;=4^494.0
